Company Filing History:
Years Active: 2004
Title: Kan Agarwal: Innovator in Gastrointestinal Research
Introduction
Kan Agarwal is a notable inventor based in Chicago, IL (US). He has made significant contributions to the field of gastrointestinal research, particularly through his innovative work on gastrokines and derived peptides.
Latest Patents
Agarwal holds a patent for a novel group of gastrokines known as Gastric Antrum Mucosal Protein. This group is characterized by a member designated as AMP-18. The genomic DNA, cDNA, and the AMP-18 protein have been sequenced for human, mouse, and pig. The AMP-18 protein and its derived active peptides serve as cellular growth factors. Interestingly, peptides that inhibit the effects of the complete protein are also derived from AMP-18. These proteins facilitate the control of mammalian gastrointestinal tissue growth and repair, making them potential candidates for therapeutic applications. He has 1 patent to his name.
Career Highlights
Kan Agarwal is affiliated with the University of Chicago, where he continues to advance his research in gastrointestinal health. His work has garnered attention for its potential impact on therapeutic strategies.
Collaborations
Agarwal collaborates with esteemed colleagues, including Terence E Martin and F Gary Toback, who contribute to his research endeavors.
Conclusion
Kan Agarwal's innovative research on gastrokines and their therapeutic potential marks him as a significant figure in the field of gastrointestinal studies. His contributions are paving the way for future advancements in medical therapies.